Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.39 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | DHFR | P00374 | 2/20 | 0.34 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8575917 | 0.89 | GABRA1 (0.39) | GABRA1GABRB2CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL9193207 | 0.85 | DHFR (0.35) | DHFR | |
| SCHEMBL9195084 | 0.83 | GABRA1 (0.38) | GABRA1GABRB2CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL9195092 | 0.82 | TYR (0.39) | GABRA1GABRB2CYP3A4 | |
| SCHEMBL9190294 | 0.81 | GABRA1 (0.33) | GABRA1GABRB2CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL9191120 | 0.80 | GABRA1 (0.44) | GABRA1GABRB2 | |
| SCHEMBL8579964 | 0.80 | GABRA1 (0.39) | GABRA1GABRB2CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL8578127 | 0.79 | GABRA1 (0.39) | GABRA1GABRB2SIRT1 | |
| SCHEMBL9193227 | 0.76 | CA1 (0.41) | CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL2678101 | 0.74 | GABRA1 (0.48) | GABRA1GABRB2CYP1A2CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0464844-B1 | Novel bis (4-(2,6-di-alkyl)phenol)silane derivatives as antiatherosclerotic agents and as antioxidants | MERRELL DOW PHARMA (US) | 1995-12-27 | — | — | EP | disclosed |
| US-5281738-A | Anticholesterol agents | MERRELL DOW PHARMACEUTICALS INC. (US) | 1994-01-25 | — | — | US | disclosed |
| EP-0464844-A1 | Novel bis (4-(2,6-di-alkyl)phenol)silane derivatives as antiatherosclerotic agents and as antioxidants | MERRELL DOW PHARMACEUTICALS INC. (US) | 1992-01-08 | — | — | EP | disclosed |